MedPath

European Organisation For Research & Treatment Of Cancer

🇬🇧United Kingdom
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.eortc.be

Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate

Phase 2
Completed
Conditions
Prostate Cancer
First Posted Date
2004-06-11
Last Posted Date
2012-09-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
116
Registration Number
NCT00085228
Locations
🇩🇰

Rigshospitalet - Copenhagen University Hospital, Copenhagen, Denmark

🇧🇪

Institut Jules Bordet, Brussels, Belgium

🇫🇷

CHU de Grenoble - Hopital de la Tronche, Grenoble, France

and more 13 locations

Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon

Phase 3
Completed
Conditions
Colorectal Cancer
First Posted Date
2004-06-11
Last Posted Date
2015-10-20
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Registration Number
NCT00085163
Locations
🇦🇹

Innsbruck Universitaetsklinik, Innsbruck, Austria

🇧🇪

Ziekenhuis Netwerk Antwerpen Middelheim, Antwerpen, Belgium

🇧🇪

CHU Liege - Domaine Universitaire du Sart Tilman, Liege, Belgium

and more 33 locations

Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma

Phase 2
Completed
Conditions
Brain and Central Nervous System Tumors
Endometrial Cancer
Gastrointestinal Stromal Tumor
Ovarian Cancer
Sarcoma
Small Intestine Cancer
First Posted Date
2004-06-03
Last Posted Date
2012-09-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
132
Registration Number
NCT00003939

Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia

Phase 2
Conditions
Leukemia
First Posted Date
2004-06-03
Last Posted Date
2009-02-09
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
60
Registration Number
NCT00003758
Locations
🇮🇹

Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore, Rome, Italy

🇳🇱

Groot Ziekengasthuis 's-Hertogenbosch, 's-Hertogenbosch, Netherlands

🇳🇱

Sint Joseph Ziekenhuis, Veldhoven, Netherlands

and more 13 locations

Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis

Phase 3
Completed
Conditions
Infection
Pulmonary Complications
First Posted Date
2004-05-27
Last Posted Date
2012-07-02
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
212
Registration Number
NCT00003031
Locations
🇦🇺

St. Vincent's Hospital, Sydney, New South Wales, Australia

🇬🇧

King's College Hospital, London, England, United Kingdom

🇪🇸

Hospital de Cruces, Barakaldo, Bilbao, Spain

and more 71 locations

High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer

Phase 3
Completed
Conditions
Head and Neck Cancer
First Posted Date
2004-05-26
Last Posted Date
2012-07-02
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
338
Registration Number
NCT00002555
Locations
🇫🇷

Hopital Jean Bernard, Poitiers, France

🇪🇸

Ciudad Sanitaria Vall D'Hebron, Barcelona, Spain

🇫🇷

Centre de Lute Contre le Cancer,Georges-Francois Leclerc, Dijon, France

and more 16 locations

BIBX 1382 in Treating Patients With Solid Tumors

Phase 1
Suspended
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2004-05-25
Last Posted Date
2012-07-11
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
80
Registration Number
NCT00003980
Locations
🇨🇭

University Hospital, Basel, Switzerland

🇨🇭

Kantonsspital - Saint Gallen, Saint Gallen, Switzerland

🇦🇹

Innsbruck Universitaetsklinik, Innsbruck, Austria

and more 24 locations

Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome

Phase 2
Withdrawn
Conditions
Myelodysplastic Syndromes
First Posted Date
2004-05-25
Last Posted Date
2012-07-11
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Registration Number
NCT00003984
Locations
🇬🇧

Western General Hospital, Edinburgh, Scotland, United Kingdom

🇬🇧

Ninewells Hospital and Medical School, Dundee, Scotland, United Kingdom

🇳🇱

Academisch Ziekenhuis der Vrije Universiteit, Amsterdam, Netherlands

and more 24 locations

KRN7000 in Treating Patients With Solid Tumors

Phase 1
Withdrawn
Conditions
Lung Cancer
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2004-05-25
Last Posted Date
2012-07-11
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Registration Number
NCT00003985
Locations
🇦🇹

Kaiser Franz Josef Hospital, Vienna, Austria

🇧🇪

Institut Jules Bordet, Brussels, Belgium

🇧🇪

Ludwig Institute for Cancer Research-Brussels Branch, Brussels, Belgium

and more 24 locations

MEN-10755 in Treating Patients With Solid Tumors

Phase 1
Completed
Conditions
Testicular Germ Cell Tumor
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2004-05-25
Last Posted Date
2012-07-11
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
30
Registration Number
NCT00003982
Locations
🇦🇹

Innsbruck Universitaetsklinik, Innsbruck, Austria

🇳🇱

Academisch Ziekenhuis der Vrije Universiteit, Amsterdam, Netherlands

🇳🇱

Rotterdam Cancer Institute, Rotterdam, Netherlands

and more 24 locations
© Copyright 2025. All Rights Reserved by MedPath